A Two-Dose Combined Vaccine Against Hepatitis A and Hepatitis B in Healthy Children and Adolescents Compared to the Corresponding Monovalent Vaccines

Archives of Medical Research - Tập 33 - Trang 67-73 - 2002
Margarita Ramonet1, Themis Reverbel da Silveira2, Mauricio Lisker-Melman3, Ricardo Rüttimann4, Eduardo Pernambuco4, Yolanda Cervantes4, Maria Cristina Cañero-Velasco5, Luiza Elena Falleiros-Carvalho6, Tania Azevedo7, Cristina Targa-Ferreira2, Sue Ann Costa Clemens4
1Unidad de Gastroenterologı́a Pediátrica, Hospital Nacional Alejandro Posadas Haedo, Buenos Aires, Argentina
2Postgraduate and Research Development, Hospital das Clinicas de Porto Alegre, Rio Grande do Sul, Brazil
3Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
4Clinical Research and Development, GlaxoSmithKline Biologicals, Latina, Rio de Janeiro, Brazil
5Unidad de Gastroenterologı́a Pediátrica, Hospital de Niños de San Justo, Buenos Aires, Argentina
6Instituto de Infectologia Emı́lio Ribas, São Paulo, Brazil
7Department of Pediatrics, Hospital Universitârio Antonio Pedro Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil

Tài liệu tham khảo

Tapia-Conyer, 1999, Hepatitis A in Latin America, Am J Trop Med Hyg, 61, 825, 10.4269/ajtmh.1999.61.825 Costa Clemens, 2000, Soroprevalencia para hepatite A e hepatite B em quatro centros no Brasil, Rev da Soc Bras Med Trop, 33, 1, 10.1590/S0037-86822000000100001 Lagos, 1999, Anticuerpos sericos contra el virus hepatitis A en sujetos de nivel socioeconomico medio y bajo, residentes en comunas urbanas de Santiago, Rev Med Chile, 127, 429 Tanno, 1999, Viral hepatitis in Latin America, Viral Hepatitis Rev, 5, 45 Silveira, 1999, Hepatitis B seroprevalence in Latin America, Pan Am J Public Health, 6, 378, 10.1590/S1020-49891999001100002 André, 1999, Over a decade of experience with a yeast-derived recombinant hepatitis B vaccine, Vaccine, 18, 57, 10.1016/S0264-410X(99)00179-6 André, 1992, Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine, Vaccine, 10, S160, 10.1016/0264-410X(92)90576-6 Tilzey, 1992, Clinical trial with inactivated hepatitis A vaccine and recommendations for its use, BMJ, 304, 1272, 10.1136/bmj.304.6837.1272 Poovorawan, 1989, Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers, JAMA, 261, 3278, 10.1001/jama.1989.03420220092033 Westblom, 1994, Safety and immunogenicity of an inactivated hepatitis A vaccine, J Infect Dis, 169, 996, 10.1093/infdis/169.5.996 Van Damme, 1994, Single dose inactivated hepatitis A vaccine, J Med Virol, 44, 435, 10.1002/jmv.1890440422 Petruff, 1997, Hepatitis vaccines, Dig Dis, 15, 1, 10.1159/000171585 Dentico, 1991, Hepatitis B virus infection in hospital staff, Vaccine, 9, 438, 10.1016/0264-410X(91)90132-P Germanaud, 1993, Prevalence of antibodies to hepatitis A virus in health care workers, Eur J Microbiol Infect Dis, 12, 572, 10.1007/BF01970972 Jacques, 1994, Hepatitis A among female day-nursery workers in Belgium, J Occ Med, 44, 259, 10.1093/occmed/44.5.259 Hadler, 1982, Risk factors for hepatitis A in day-care centers, J Infect Dis, 145, 255, 10.1093/infdis/145.2.255 Carletti, 1992, HBV infection in hemodialysis patients, Nephron, 61, 269, 10.1159/000186901 Kumar, 1993, Serologic markers of viral hepatitis A, B, C and D in patients with hemophilia, J Med Virol, 41, 205, 10.1002/jmv.1890410307 Mannucci, 1994, Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses, Ann Intern Med, 120, 1, 10.7326/0003-4819-120-1-199401010-00001 Vento, 1998, Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C, N Engl J Med, 338, 286, 10.1056/NEJM199801293380503 Tsai, 1994, Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma, Liver, 14, 98, 10.1111/j.1600-0676.1994.tb00055.x Keefe, 1998, Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease, Hepatology, 27, 881, 10.1002/hep.510270336 Thoelen, 1999, The first combined vaccine against hepatitis A and B, Vaccine, 17, 1657, 10.1016/S0264-410X(98)00421-6 Lee, 1999, A two dose combined hepatitis A and B vaccine in Chinese youngsters, J Med Virol, 59, 1, 10.1002/(SICI)1096-9071(199909)59:1<1::AID-JMV1>3.0.CO;2-F Van Damme, 2001, Combining hepatitis A and B vaccination in children and adolescents, Vaccine, 19, 2407, 10.1016/S0264-410X(00)00464-3 Ambrosch, 1994, Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine, J Med Virol, 44, 452, 10.1002/jmv.1890440426 Czeschinski, 2000, Hepatitis A and hepatitis B vaccinations, Vaccine, 18, 1074, 10.1016/S0264-410X(99)00354-0 Leroux-Roels, 1996, Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young, healthy adults, Scand J Gastroenterol, 31, 1027, 10.3109/00365529609003124 Reutter, 1998, Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/B vaccination in 242 adult volunteers, J Viral Hepatitis, 5, 205, 10.1046/j.1365-2893.1998.00101.x Van Herck, 1999, Two dose combined vaccination against hepatitis A and B in healthy subjects aged 11–18 years, Scand J Gastroenterol, 34, 1236, 10.1080/003655299750024760 Frey, 1999, Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine, J Infect Dis, 180, 2018, 10.1086/315119 Kallinowski, 2001, Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?, Vaccine, 19, 16, 10.1016/S0264-410X(00)00166-3